Lpath Inc. (LPTN) Stock Quote

Detailed Quote for Lpath Inc. (LPTN)

close 52 Week Information

52Wk High

July 31, 2012

Close: 48.51

52Wk Low

March 4, 2013

Close: 4.13

Today

Last Price
4.99

Change $
0.04

Change %
0.81%

Tick

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
4.87

High
5.0004

Low
4.87

Prev Close
4.95

Last Trade
05/17/13

Volume
18.63 k

52 Wk Hi
48.51

52 Wk Low
4.13

Market Cap
65.51 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
13,128,250

EPS (TTM)
-0.26

PE Ratio
N/A

close Market Information Listed On Nasdaq Small Caps (NSC) Exchange
NSC

News and Media for Lpath Inc. (LPTN)

Sector News | Topic News

News for LPTN

Tue, Apr 16, 2013

4:15 PM

Lpath Adds Two Key Members to its Executive Team - Globe Newswire

Fri, Mar 22, 2013

8:31 AM

Lpath Granted Key European and U.S. Patents Related to Anti-Cancer Drug Program, ASONEP - Marketwired

Tue, Mar 12, 2013

8:31 AM

Lpath to Present at ROTH Capital Partners 25th Annual Growth Stock Conference on March 19, 2013 - Marketwired

Wed, Mar 06, 2013

11:15 AM

Lpath Signs Collaboration and License Agreement With Provista Diagnostics to Develop Cancer Diagnostics - Marketwired

Mon, Feb 25, 2013

8:31 AM

Lpath to Present Data at Arrowhead's 3rd Annual Traumatic Brain Injury Conference on March 7, 2013 - Marketwired

Wed, Feb 13, 2013

8:31 AM

Lpath Promotes Leigh Hsu, Ph.D., to Vice President of Corporate Development - Marketwired

Fri, Jan 18, 2013

7:01 AM

Rumors, News and Biotech Buzz Present Various Trade Opportunities - Marketwired

Wed, Dec 26, 2012

8:31 AM

Lpath Sets Investor Update Conference Call for Thursday, January 3, 2013 at 4:30 p.m. ET - Marketwired

Fri, Dec 14, 2012

9:10 AM

Lpath Announces Pricing of Public Offering of Common Stock - Marketwired

Thu, Dec 13, 2012

4:02 PM

Lpath Announces Proposed Public Offering of Common Stock - Marketwired

Wed, Dec 05, 2012

8:31 AM

Lpath Granted Key European Patent Related to iSONEP Drug Program - Marketwired

Mon, Dec 03, 2012

8:31 AM

Lpath Ranks Eighth Fastest Growing Biotechnology Company and 60th Overall Among N. America's Fastest Growing Companies in Deloitte's 2012 Technology Fast 500 - Marketwired

Fri, Nov 02, 2012

7:53 PM

Lpath Announces Filing of Shelf Registration Statement - Marketwired

Wed, Oct 17, 2012

3:11 PM

Lpath to Begin Trading on NASDAQ Capital Market October 22, 2012 - Marketwired

Thu, Oct 04, 2012

8:31 AM

Lpath Announces Reverse Split of Class A Common Stock - Marketwired

Wed, Oct 03, 2012

8:31 AM

Lpath Begins iSONEP Dosing in Nexus Phase 2 Study - Marketwired

Mon, Aug 27, 2012

8:31 AM

FDA Lifts Clinical Hold on Lpath's iSONEP - Marketwired

Fri, Aug 24, 2012

2:46 PM

Lpath to Present at the 2012 Gateway Conference on September 6 - Marketwired

Thu, Mar 01, 2012

7:19 AM

Keeping an eye on Lpath as shares look to build momentum - Accesswire

Tue, Dec 06, 2011

11:13 AM

Set to move: Three micro-cap stocks that analysts and instituional investors like - Accesswire

More News for LPTN >>

Tags for Lpath Inc.

Research stocks or mutual funds related to Lpath Inc. by keywords or tags. Find companies that have a similar focus to LPTN. The keywords below have been associated to LPTN by either user submission or electronic means.

microcurrent macular degeneration clinical trials database human monoclonal antibody clinical research trial clinical development clinical cost antibody protein clinical pharmacology cv therapeutics stock clinical research consulting outsourcing clinical trials angiogenesis inhibitors Biological Products corporate governance clinical investigators cra clinical research cv therapeutics clinical research clinical research investigators board of directors role clinical trials manager board of directors governance board compensation antibodies directors duties board governance human antibodies Drugs monospecific antibodies pain therapeutics cardiology clinical trials clinical trials conference board of directors info medical device clinical trial cedra clinical research board of directors compensation board of directors responsibility cellegy pharmaceuticals international clinical trials board responsibilities clinical data medical trials monoclonal antibody Healthcare corporate governance board of directors monitoring clinical research clinical research guidelines clinical outsourcing clinical research investigator monospecific antibody